Fusion Pharmaceuticals Inc logo

FUSN - Fusion Pharmaceuticals Inc News Story

$8.56 0.0  0.0%

Last Trade - 21/09/21

Sector
Healthcare
Size
Small Cap
Market Cap £269.6m
Enterprise Value £138.9m
Revenue £381k
Position in Universe 4085th / 7157

BRIEF-Fusion Pharmaceuticals Announces FDA Clearance Of Ind For Fpi-1966, An Investigational Radiopharmaceutical For The Treatment Of Head And Neck And Bladder Cancers Expressing Fgfr3

Wed 28th July, 2021 9:59pm
July 28 (Reuters) - Fusion Pharmaceuticals Inc  FUSN.O :
    * FUSION PHARMACEUTICALS ANNOUNCES FDA CLEARANCE OF IND FOR
FPI-1966, AN INVESTIGATIONAL RADIOPHARMACEUTICAL FOR THE
TREATMENT OF HEAD AND NECK AND BLADDER CANCERS EXPRESSING FGFR3
    * FUSION - PLANS TO INITIATE PHASE 1, NON-RANDOMIZED,
OPEN-LABEL
CLINICAL TRIAL IN PATIENTS WITH SOLID TUMORS EXPRESSING FGFR3

Source text for Eikon:  ID:nPn5BmWXfa 
Further company coverage:  FUSN.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.